Mercury Laboratories [MERCURYLAB] vs Innova Captab [INNOVACAP] Detailed Stock Comparison
Mercury Laboratories
BSE
Loading...
Innova Captab
NSE
Loading...
TLDR: Quick Comparison Summary
Based on 20 vital metrics comparison: Mercury Laboratories wins in 11 metrics, Innova Captab wins in 7 metrics, with 0 ties. Mercury Laboratories appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | Mercury Laboratories | Innova Captab | Better |
|---|---|---|---|
| P/E Ratio (TTM) | 26.09 | 38.54 | Mercury Laboratories |
| Price-to-Book Ratio | 1.84 | 5.21 | Mercury Laboratories |
| Debt-to-Equity Ratio | 10.18 | 35.24 | Mercury Laboratories |
| PEG Ratio | 0.14 | 7.35 | Mercury Laboratories |
| EV/EBITDA | 13.90 | 27.61 | Mercury Laboratories |
| Profit Margin (TTM) | 4.93% | 9.98% | Innova Captab |
| Operating Margin (TTM) | 8.34% | 11.68% | Innova Captab |
| EBITDA Margin (TTM) | 8.34% | 11.68% | Innova Captab |
| Return on Equity | 5.87% | 13.37% | Innova Captab |
| Return on Assets (TTM) | 4.23% | 8.12% | Innova Captab |
| Free Cash Flow (TTM) | $-50.39M | $-1.09B | Mercury Laboratories |
| Dividend Yield | 0.82% | N/A | N/A |
| 1-Year Return | -17.07% | 15.25% | Innova Captab |
| Price-to-Sales Ratio (TTM) | 1.29 | 3.84 | Mercury Laboratories |
| Enterprise Value | $1.02B | $52.65B | Innova Captab |
| EV/Revenue Ratio | 1.34 | 4.05 | Mercury Laboratories |
| Gross Profit Margin (TTM) | 60.02% | 37.21% | Mercury Laboratories |
| Revenue per Share (TTM) | $638 | $227 | Mercury Laboratories |
| Earnings per Share (Diluted) | $31.43 | $22.68 | Mercury Laboratories |
| Beta (Stock Volatility) | 0.57 | N/A | N/A |
Performance
News Sentiment
Key Stats
Valuation
Financials
Short Interest
Dividends
Mercury Laboratories vs Innova Captab Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| Mercury Laboratories | 3.66% | 3.84% | 1.80% | -0.74% | 1.18% | -4.50% |
| Innova Captab | -2.56% | 0.59% | -7.07% | -0.71% | -5.56% | -23.39% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Mercury Laboratories | -17.07% | 42.15% | 92.55% | 110.81% | 2,274.30% | 2,274.30% |
| Innova Captab | 15.25% | 57.00% | 57.00% | 57.00% | 57.00% | 57.00% |
News Based Sentiment: Mercury Laboratories vs Innova Captab
Mercury Laboratories
News based Sentiment: MIXED
September presented a mixed bag for Mercury Laboratories, with a positive valuation upgrade countered by concerns over profitability and a declining share price over the past year. The volatility and conflicting signals make it a significant month for investors to assess the company's direction.
Innova Captab
News based Sentiment: MIXED
September brought a blend of positive and negative developments for Innova Captab. While the company demonstrated continued profitability with its Q2 results, the share price experienced volatility and there were notable shifts in institutional investor holdings. The credit rating revision adds another layer of complexity, making it a mixed month overall.
Performance & Financial Health Analysis: Mercury Laboratories vs Innova Captab
| Metric | MERCURYLAB | INNOVACAP |
|---|---|---|
| Market Information | ||
| Market Cap | ₹1.02B | ₹48.64B |
| Market Cap Category | Small cap | Small cap |
| 10 Day Avg. Volume | 28 | 25,850 |
| 90 Day Avg. Volume | 138 | 38,302 |
| Last Close | ₹850.00 | ₹850.00 |
| 52 Week Range | ₹736.00 - ₹1,190.00 | ₹662.00 - ₹1,260.00 |
| % from 52W High | -28.57% | -32.54% |
| All-Time High | ₹1,303.00 (Jan 08, 2024) | ₹1,260.00 (Jan 06, 2025) |
| % from All-Time High | -34.77% | -32.54% |
| Growth Metrics | ||
| Quarterly Revenue Growth | 0.09% | 0.20% |
| Quarterly Earnings Growth | 1.83% | 0.05% |
| Financial Health | ||
| Profit Margin (TTM) | 0.05% | 0.10% |
| Operating Margin (TTM) | 0.08% | 0.12% |
| Return on Equity (TTM) | 0.06% | 0.13% |
| Debt to Equity (MRQ) | 10.18 | 35.24 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | ₹446.41 | ₹167.66 |
| Cash per Share (MRQ) | ₹12.97 | ₹11.41 |
| Operating Cash Flow (TTM) | ₹-12,625,000 | ₹282.88M |
| Levered Free Cash Flow (TTM) | ₹31.45M | ₹1.28B |
| Dividends | ||
| Last 12-Month Dividend Yield | 0.82% | N/A |
| Last 12-Month Dividend | ₹7.00 | N/A |
Valuation & Enterprise Metrics Analysis: Mercury Laboratories vs Innova Captab
| Metric | MERCURYLAB | INNOVACAP |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | 26.09 | 38.54 |
| Forward P/E | N/A | 20.43 |
| PEG Ratio | 0.14 | 7.35 |
| Price to Sales (TTM) | 1.29 | 3.84 |
| Price to Book (MRQ) | 1.84 | 5.21 |
| Market Capitalization | ||
| Market Capitalization | ₹1.02B | ₹48.64B |
| Enterprise Value | ₹1.02B | ₹52.65B |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 1.34 | 4.05 |
| Enterprise to EBITDA | 13.90 | 27.61 |
| Risk & Other Metrics | ||
| Beta | 0.57 | N/A |
| Book Value per Share (MRQ) | ₹446.41 | ₹167.66 |
Financial Statements Comparison: Mercury Laboratories vs Innova Captab
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
| Metric (MRQ) | MERCURYLAB | INNOVACAP |
|---|---|---|
| Revenue/Sales | ₹181.35M | ₹3.52B |
| Cost of Goods Sold | ₹72.50M | ₹2.21B |
| Gross Profit | ₹108.85M | ₹1.31B |
| Research & Development | N/A | N/A |
| Operating Income (EBIT) | ₹15.12M | ₹410.54M |
| EBITDA | ₹25.36M | ₹565.82M |
| Pre-Tax Income | ₹15.47M | ₹426.77M |
| Income Tax | ₹5.80M | ₹116.62M |
| Net Income (Profit) | ₹9.68M | ₹310.15M |
Balance Sheet & Liquidity Metrics (MRQ)
| Metric (MRQ) | MERCURYLAB | INNOVACAP |
|---|---|---|
| Cash & Equivalents | ₹3.32M | ₹155.19M |
| Total Current Assets | ₹401.60M | ₹7.03B |
| Total Current Liabilities | ₹150.76M | ₹3.53B |
| Long-Term Debt | ₹37.83M | ₹2.45B |
| Total Shareholders Equity | ₹535.69M | ₹9.59B |
| Retained Earnings | ₹86.56M | ₹4.53B |
| Property, Plant & Equipment | ₹85.40M | ₹442.93M |
Cash Flow Statement Comparison (MRQ)
| Metric (MRQ) | MERCURYLAB | INNOVACAP |
|---|---|---|
| Operating Cash Flow | N/A | ₹378.60M |
| Capital Expenditures | N/A | ₹-1.21B |
| Free Cash Flow | N/A | ₹-908.56M |
| Debt Repayment | N/A | ₹-7.69M |
| Common Stock Repurchase | N/A | N/A |
Short Interest & Institutional Ownership Analysis
| Metric | MERCURYLAB | INNOVACAP |
|---|---|---|
| Shares Short | N/A | N/A |
| Short Ratio | N/A | N/A |
| Short % of Float | N/A | N/A |
| Average Daily Volume (10 Day) | 28 | 25,850 |
| Average Daily Volume (90 Day) | 138 | 38,302 |
| Shares Outstanding | 1.20M | 57.22M |
| Float Shares | 166,416 | 15.70M |
| % Held by Insiders | 0.86% | 0.72% |
| % Held by Institutions | 0.00% | 0.19% |
Dividend Analysis & Yield Comparison: Mercury Laboratories vs Innova Captab
| Metric | MERCURYLAB | INNOVACAP |
|---|---|---|
| Last 12-Month Dividend | ₹7.00 | N/A |
| Last 12-Month Dividend Yield | 0.82% | N/A |
| 3-Year Avg Annual Dividend | ₹4.67 | N/A |
| 3-Year Avg Dividend Yield | 0.43% | N/A |
| 3-Year Total Dividends | ₹14.00 | N/A |
| Ex-Dividend Date | Aug 06, 2025 | N/A |